In breast cancer, PML regulates aggressiveness and metastatic features through the control of the stem cell gene, SOX9, and the Hypoxia-inducible factor 1 alpha (HIF1α) signaling [13, 15]. The gene discussed is HIF1A; the disease is breast cancer.